2014;11:1305 23. S7.6-18. Mehta D, Mori N, Goldbarg SH, et al. Primary prevention of sud- den cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2011;4:43 8. 7.6.1. Other Infiltrative Cardiomyopathies S7.6.1-1. Lubitz SA, Goldbarg SH, Mehta D, Sudden cardiac death in infiltra- tive cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hema- chromatosis. Prog Cardiovasc Dis. 2008;51:58 73. S7.6.1-2. Kristen AV, Dengler TJ, Hegenbart U, et al. Prophylactic implanta- tion of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm. 2008;5:235 40. S7.6.1-3. Sperry BW, Ikram A, Hachamovitch R, et al. Efficacy of chemother- apy for light-chain amyloidosis in patients presenting with symp- tomatic heart failure. J Am Coll Cardiol. 2016;67:2941 8. S7.6.1-4. Varr BC, Zarafshar S, Coakley T, et al. Implantable cardioverter- defibrillator placement in patients with cardiac amyloidosis. Heart Rhythm. 2014;11:158 62. 7.7. Heart Failure 7.7.1. HF With Reduced Ejection Fraction S7.7.1-1. Frohlich GM, Holzmeister J, Hubler M, et al. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation. Heart. 2013;99:1158 65. S7.7.1-2. Kao AC, Krause SW, Handa R, et al. Wearable defibrillator use in heart failure (WIF): results of a prospective registry. BMC Cardiovasc Disord. 2012;12:123. S7.7.1-3. Opreanu M, Wan C, Singh V, et al. Wearable cardioverter-defibrilla- tor as a bridge to cardiac transplantation: a national database analy- sis. J Heart Lung Transplant. 2015;34:1305 49. S7.7.1-4. Sandner SE, Wieselthaler G, Zuckermann A, et al. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation. 2001;104:171 6. S7.7.1-5. Vakil K, Duval S, Cogswell R, et al. Impact of implantable cardio- verter-defibrillators on waitlist mortality among patients await- ing heart transplantation. An UNOS/OPTN Analysis. JACC Clin Electrophysiol. 2017;3:33 40. S7.7.1-6. Packer DL, Prutkin JM, Hellkamp AS, et al. 